Endometriosis
Open accessThe DOI matches its Crossref record; 208 of the 214 references it cites were found in a registry or an index.
Abstract
Pelvic endometriosis is a complex syndrome characterized by an estrogen-dependent chronic inflammatory process that affects primarily pelvic tissues, including the ovaries. It is caused when shed endometrial tissue travels retrograde into the lower abdominal cavity. Endometriosis is the most common cause of chronic pelvic pain in women and is associated with infertility. The underlying pathologic mechanisms in the intracavitary endometrium and extrauterine endometriotic tissue involve defectively programmed endometrial mesenchymal progenitor/stem cells. Although endometriotic stromal cells, which compose the bulk of endometriotic lesions, do not carry somatic mutations, they demonstrate specific epigenetic abnormalities that alter expression of key transcription factors. For example, GATA-binding factor-6 overexpression transforms an endometrial stromal cell to an endometriotic phenotype, and steroidogenic factor-1 overexpression causes excessive production of estrogen, which drives inflammation via pathologically high levels of estrogen receptor-β. Progesterone receptor deficiency causes progesterone resistance. Populations of endometrial and endometriotic epithelial cells also harbor multiple cancer driver mutations, such as KRAS, which may be associated with the establishment of pelvic endometriosis or ovarian cancer. It is not known how interactions between epigenomically defective stromal cells and the mutated genes in epithelial cells contribute to the pathogenesis of endometriosis. Endometriosis-associated pelvic pain is managed by suppression of ovulatory menses and estrogen production, cyclooxygenase inhibitors, and surgical removal of pelvic lesions, and in vitro fertilization is frequently used to overcome infertility. Although novel targeted treatments are becoming available, as endometriosis pathophysiology is better understood, preventive approaches such as long-term ovulation suppression may play a critical role in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since P4 signaling is required to counteract E2-induced proliferation and to promote decidualization [55], the loss of P4-responsiveness leads to both an increased growth of endometriotic lesions and to a non-receptive endometrium [33, 56].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During the follicular phase, estrogen acts on eutopic endometrium through the estrogen receptor (ER) to increase transcription and protein levels of the progesterone receptor (PR), especially the PR-B isoform.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in endometriotic implants, ERα is reduced but ERβ activity is upregulated, leading to complete loss of PR-B, which is then unable to induce 17β-HSD2.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Clear data show that endometriotic tissue expresses the entire set of steroidogenic genes, including aromatase, allowing to local de-novo estradiol (E2) production. [33]”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“PR resistance in endometriotic cells results in CRABP2 deficiency, thereby favoring survival, development and persistence of endometriotic implants [15,16].”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [15]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Sampson, J. A. (1927) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30003-x · Cited by 2,334
Endometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940
Giudice, L. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1000274 · Cited by 1,924
Bulun, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804690 · Cited by 1,772
Self-citationARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Eskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
(1927) · PubMed Central · Cited by 1,008
Immunobiology of endometriosis
Lebovic, D. I., Mueller, M. D., & Taylor, R. N. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01630-7 · Cited by 857
Research works printed but not linked: 3
- Evers J, Dunselman G, Land J, Bouckaert P, Van Der Linden P. Management of recurrent endometriosis. In: Coutinho EM, Spinola P, Hanson de Moura L, eds. Progress in the Management of Endometriosis. London, UK: Parthenon Publishing Group; 1995:291–297. [Google Scholar]
- Bulun SE. Endometriosis. In: Strauss J, Barbieri R, eds. Yen & Jaffe’s Reproductive Endocrinology. 8th ed. Philadelphia, PA: Elsevier; 2019:609–642. [Google Scholar]
- Bulun S, Adashi E. The physiology and pathology of the female reproductive axis. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology, 10th ed. Philadelphia, PA: Elsevier Health Sciences; 2003:587–663. [Google Scholar]
Cited by
Items 901–944 of 944
Maldonado, G., Espinoza, C., Arias, A., Munoz, A., Cabrera, G., Johnson, M. C., Espinoza, J. P., Gutiérrez, I., González, P., Owen, G., et al. (2026) · Cells and Development · doi:10.1016/j.cdev.2026.204096
Steroidal alkaloids as multi-target therapeutics for the treatment of endometriosis
Shirodkar, S., & Doshi, G. (2026) · Steroids · doi:10.1016/j.steroids.2026.109827
Weber, I., Parra, I. B., Sansone, L. L., Alencar, A. C. F., & Prado, I. P. (2026) · Editora Pasteur eBooks · doi:10.59290/4420214050
Takaoka, O., Okimura, H., Tarumi, Y., Kawamata, M., Ito, F., Koshiba, A., Kusuki, I., Kitawaki, J., & Mori, T. (2026) · Research Square · doi:10.21203/rs.3.rs-9799296/v1
Site-dependent transcriptomic signatures of endometriosis are conserved across hormonal statesPreprint
Henze, D. E., Crowley, G., & Quake, S. R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.10.737856
Aghajanzadeh, F., Majlesi, Z. A., Koutenaie, A., Jomehpour, F., Abtahian, A., Asadi, F., Lordejani, N. A., & Azimi, S. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117152
Effects of lactoferrin and progesterone on the endometriotic lesion in a female rat model
Şenyuva, İ., Acar, D. B., Bayat, H. H. D., Çoban, F. K., & TUNÇ, E. (2026) · Asian Biomedicine · doi:10.2478/abm-2026-0019
Trokhymovych, О. V., Poluianova, O. M., Чубей, Г. В., Kaliuta, A. O., Zinchenko, M. V., & Блажко, О. І. (2026) · Reproductive health of woman · doi:10.30841/2708-8731.4.2026.368215
Phthalate exposure and human reproductive health: an epidemiological review
Binyu, S., Shi, H., Liu, X., Zeng, M., Yuan, Z., & Xiao, Y. (2026) · Drug and Chemical Toxicology · doi:10.1080/01480545.2026.2711644
Pokorska‐Niewiada, K., Szczuko, M., Kayumov, K., & Janda, K. (2026) · Antioxidants · doi:10.3390/antiox15081003
“Despite its high prevalence and substantial impact on quality of life, currently available therapeutic options remain limited in efficacy and are frequently associated with considerable adverse effects or high recurrence rates [1,2].”
Shifon, S., Викторовна, Т. Т., Veretel’nikova, T. V., Maksimova, А. А., Ращупкин, И. М., Пасман, Н. М., & Chernykh, E. R. (2026) · Biomarkers · doi:10.1080/1354750x.2026.2718915
“…in the concentration of th2 cytokines that promote M2 macrophage polarization and the formation of chronic inflammation with fibrotic remodelling (Bulun et al. 2019). this is consistent with the data of Xiao et al. (2020) on the role of the th2 immune response in fibrogenesis in…”
Narratives on Sexuality in Vulvodynia and Endometriosis: A Qualitative Study on Italian Couples
Fabbri, E., Rasolo, G., Rinaldi, M., & Chiara, G. (2026) · Archives of Sexual Behavior · doi:10.1007/s10508-026-03507-0
“Endometriosis is a complex gynecological condition characterized by the growth of endometrium-like tissue outside the uterus (Bulun et al., 2019; Mick et al., 2024).”
Postmenopausal endometriosis: current evidence and clinical challenges in diagnosis and treatment
Lalla, A., Kohn, J. R., Pasternak, D., & Guan, X. (2026) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000001127
卢, 思., & 陈, 萌. (2025) · 健康文摘 · doi:10.61654/zzjkwz111002
Wang, Z., Yang, J., Yan, B., & Xie, G. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s629329
Gendered Illnesses and Embodied Knowledge: A Phenomenological Body-Mapping Study of Endometriosis
Bisig, K. A., Idrees, S., & Hannes, K. (2026) · International Journal of Social Determinants of Health and Health Services · doi:10.1177/27551938261473770
Risk factors for intraoperative adhesion in ovarian endometriosis patients: A retrospective study
Zhou, L., Tong-fei, W., Feng, X.-S., Lai, Z.-Z., Chen, D.-Z., Chen, P.-F., Jiang, T.-T., Wang, H.-L., & Zheng, Z.-Q. (2026) · Medicine · doi:10.1097/md.0000000000050604
“[14] Following the implantation of endometrial tissue into the peritoneum, inflammatory cells such as neutrophils and macrophages are recruited, which in turn induce the secretion of inflammatory and angiogenic factors, including tumor necrosis factor, interleukin-1, interleukin-6 and vascular…”
Engineering the human endometrium at the intersection of development and reproduction
Vélez-Avilés, A. N., Abel, A., Taylor, H. S., & Sözen, B. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01789-2
“Ectopic lesions contain endometrial-like epithelial and stromal populations but acquire site-and subtype-specific states characterized by fibrosis, chronic inflammation, enhanced angiogenesis and altered immune activity 131,132 .”
Huang, J., Chen, H., Li, Z., Zhang, Z., Qin, Y., & Wang, L. (2026) · American Journal of Translational Research · doi:10.62347/acdy5165
Zanesco, A. M., Tonet, N. S., Araújo, M. M., Botelho, P. B., & Velloso, L. A. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00125.2026
Utility of Pelvic Magnetic Resonance Imaging in a Younger Population
Ida, Y., Sano, R., Komoto, T., Izumori, M., Okamoto, M., Sasaki, K., Hara, Y., Joja, I., Miyake, T., & Miyake, T. (2026) · Cureus · doi:10.7759/cureus.116381
“The higher prevalence of organic diseases among adults likely reflects the cumulative effect of estrogen exposure since menarche [13,22,23].”
Adamyan, L. V., Krechetova, K. L. V., Menzhinskaya, M. I. V., Inviyaeva, E. V., Khaidukov, S. V., Antonova, A. A., Pivazyan, L. G., Avetisyan, J. S., & Seregina, V. Y. (2026) · Russian Journal of Human Reproduction · doi:10.17116/repro20263204160
Hunsche, E., Rakov, V. G., Coppola, J., & Agarwal, S. K. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s594255
DIAGNOSTIC AND THERAPEUTIC CHALLENGES IN ENDOMETRIOSIS: A NARRATIVE REVIEW
Krupska, A., Brzózka, K., Ledwożyw, K., Piełuć, A., Pyrka, Z., & Cionżyńska, W. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.5926
Francone, N. O., Bulun, S. E., Ma, Y., Yilmaz, B., Akin-Olugbade, O. O., Bernardi, L. A., Jungheim, E. S., Feinberg, E. C., Boots, C. E., PhD, M. K., et al. (2026) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2026.105982 · Cited by 1
Self-citationWhat awaits after menopause? Endometriosis, menopause and hormonal treatment: A systematic review
Liu, Q., Alastruey, C., Martínez‐Zamora, M. Á., & Gracia, M. (2026) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/j.gine.2026.101142
Endometriosis: por qué duele tanto y cómo se estudia en el laboratorio
Trujillo, A., Rivera, N. P., & Castro, N. P. (2026) · RD-ICUAP · doi:10.32399/icuap.rdic.2448-5829.2026.35.1713
OBESITY, ENDOMETRIOSIS, AND GLP-1 RECEPTOR AGONISTS: A NARRATIVE REVIEW
Wróblewska, O., Majewski, J., Witaszczyk, M., Hałabuda, Z., Jędryka, M., Paczyna, J., Benecka, A., & Kawka-Bryk, I. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6411
Thengkano, I., Dwiningsih, S. R., Primariawan, R. Y., & Hernaningsih, Y. (2026) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.2026.18471
Clinical Efficacy Of Alternative Therapy For Adenomyosis
Doshchanova, A. M., Тулетова, А. С., & Kenzhebekovna, S. L. (2023) · Journal for ReAttach Therapy and Developmental Diversities
Uso de biomarcadores moleculares en el diagnóstico precoz y la evolución de la endometriosis
Espín, M. G. T., Rodas-Castillo, J. L., Logro, D. M. U., & Nuñez-Arroba, S. D. P. (2025) · Revista de Ciencias Médicas de Pinar del Río
Azizova, Z. S., Eshimbetova, G. Z., & A., A. M. (2026) · Modern American Journal of Medical and Health Sciences
Herszon, M. R., Rocha, R. S., Freitas, F. M. N. D. O., & dos Reis, D. S. (2026) · Periódicos Brasil Pesquisa Científica · doi:10.36557/2674-9432.2026v5n8p127-149
Wang, J., Li, Y., Zhang, H., Yiling, Z., Fan, W., Xin, W., Qiang, C., & Qin, T. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1917718
“These symptoms can substantially impair fertility and quality of life (3).”
Sleep Quality Among Women with Endometriosis in Bangladesh: A Hospital- Based Cross-Sectional StudyPreprint
Muztoba, M., Afrose, A., Marzan, M., & Haque, M. (2026) · Research Square · doi:10.21203/rs.3.rs-10861739/v1
Werdin, S., Wang, Z., Huffman, E., Jukic, A. M. Z., Wilcox, A. J., Suharwardy, S. H., Onnela, J.-P. “., Coull, B. A., Williams, M. A., & Mahalingaiah, S. (2026) · medRxiv · doi:10.64898/2026.10.13.26365449
The hormonal regulation of endometriosis and adenomyosis
Velho, R. V., & Mechsner, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27757-3.00006-7
Multimodal investigation of endometriosis by using LA-ICP-MS and QCL-based infrared microscopyPreprint
Hingst, D., Weiss, J., Velho, R. V., Pellowski, D., Schuessler, C., Weigel, S., Haase, H., Mechsner, S., Karst, U., & Maares, M. (2026) · medRxiv · doi:10.64898/2026.10.22.26366152
Endometriosis and Its Impact on Sexual Life
Falconnier, A., & Schulte, V. (2026) · Springer eBooks · doi:10.1007/978-3-662-74275-4_1
Hydroxysafflor yellow A ameliorates progression of endometriosis via regulating PPAR-γ/PTEN/Akt axis
李俊利, Zhao, N., Lu, Y., Huang, X., Qiu, Y., Zhou, X., & Wang, Y. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.104095
Nerve-Sparing Surgery for Parametrial Endometriosis
Moustafa, S., Zaradna, A., Uzianbaeva, L., Mehdizadeh, A., Fan, D., & Pengfei, W. (2026) · JSLS Journal of the Society of Laparoscopic & Robotic Surgeons · doi:10.4293/jsls.2026.00109
Protease‐Activated Theranostic Nanomedicine for Endometriosis Treatment
Kumar, P. P. P., Kim, T. H., Hosseinirad, H., Lee, M., An, H., Lessey, B. A., Hanavi, D., Shin, J., Jeong, J., & Kim, T. (2026) · Advanced Functional Materials · doi:10.1002/adfm.79366
Jabbar, Z. B., Al-Shaikh, S. F., & Shemran, K. A. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00338-w
Ge, X., Ruan, L., Huang, H., 董燕群, & Zhu, T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1932061
Metadata
- Authors
- Bulun, S. E., Yilmaz, B. D., Sison, C., Miyazaki, K., Bernardi, L., Liu, S., Kohlmeier, A., Yin, P., Milad, M., & Wei, J.
- Affiliations
- Northwestern University (US)
- Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
- Corresponding author
- Bulun, Serdar E
- ORCID
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-04-17
- Volume
- 40
- Issue
- 4
- Pages
- 1048-1079
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC6693056
- OpenAlex
- W4211072069
- Semantic Scholar
- 65040787dce0d5e2c5ea1422c1499c9646f18963
- Cited by
- 844
- References
- 214
- Citations by year
- 2026: 105 · 2025: 163 · 2024: 158 · 2023: 134 · 2022: 121 · 2021: 91 · 2020: 64 · 2019: 8
- FWCI
- 10.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Child Health and Human Development (HD38691)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- pelvic endometriosis, chronic pelvic pain, infertility, endometrial mesenchymal stem cells, epigenetic abnormalities, GATA6, steroidogenic factor 1, estrogen receptor beta, progesterone resistance, KRAS mutation, ovarian cancer, ovulation inhibition, cyclooxygenase inhibitors, in vitro fertilization, targeted therapy
- MeSH terms
- Animals, Endometriosis, Endometrium, Female, Humans, Receptors, Progesterone, Uterine Diseases, Stromal Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.